CET and skills guides

Study and gain CET points through OT’s online CET exams, and access archived CET, CPD articles and skills guides in our education library

Find out more

Science and vision

News and features about the latest scientific developments and advances in optometry, ophthalmology and eye medicine

Find out more

Professional support

News and features about the latest developments relating to professional support from across optics. This includes updates from optical organisations such as the AOP and the GOC

Find out more

In practice

News and in-depth features about business management and career development in optics

Find out more


Explore the latest UK and global jobs in the optical sector for optometrists, dispensing opticians and more

Find out more

A preventative tool

A new instrument could be used by opticians to determine a patient’s chances of developing AMD

Eye image

An instrument that could help identify individuals at risk of developing a common eye condition that can cause blindness is being designed in partnership between Azul Optics, the University of Bristol Enterprise Fund and a group of entrepreneurs.

Azul Optics is in the process of developing the ophthalmic instrument, which it says will enable the “rapid and cost-effective screening” of patients to determine their susceptibility to age-related macular-degeneration (AMD).

The device was the idea of Dr Shelby Temple from the University of Bristol’s School of Biological Science, and it is hoped that in the future the tool could be used in optical practices as a preventative eye health method in the same way that screening for retinopathy and glaucoma is used today.

Chief executive of Azul Optics, Joseph Cefai, highlighted that AMD is the leading cause of incurable blindness in the western world, affecting up to one-in-10 people over the age of 65. He explained that: “By screening for low macular pigment density, opticians could advise people to make lifestyle changes early that can help prevent the problem developing.”

A prototype of the instrument has already been developed and evaluated by Dr Temple, with Azul Optics’ aiming now to develop the tool and make it commercially available to opticians, Mr Cafai told OT.

Recognising the instrument’s potential, Azul Optics has invested £310,000 into the development project, while the Bristol Private Equity Club has provided £160,000 and the University of Bristol Enterprise Fund has boosted this further still with £150,000 contribution.

"We hope that with this funding we can bring the device to the market within 18 months," Mr Cafai added.